IBD 50: Top 5 Medical Stocks Include Celgene, Actavis
Investors Business Daily
Biogen: Will it Miss Earnings Again?
Yahoo/Zacks
Biogen's MS Pill Roars Out Of Launch Gate
TheStreet.com
This Week in Biotech
Motley Fool
Biogen Hits Primary Endpoints in MS Study
Motley Fool
Is Teva Just Looking Out for Itself
Motley Fool
2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool

